I am currently writing a paper on, as the topic title suggests, pharmacology in the post genomic era and was wondering if anybody had any input? I am specifically interested in any information on current, so called, tailor made drugs that are being produced and distributed today. I am also interested in any development in new drug targets, especially involving the discovery of orphan receptors. Thanks for any help.

SJ

on PPAR Gamma ( orphan receptor) and their ligands ( which here have been a lot of publications on the topic you are interested in.